Centene Corporation (LON:0HVB)
London · Delayed Price · Currency is GBP · Price in USD 35.99
+0.79 (2.23%)
At close: Oct 20, 2025
Centene Market Cap
Centene has a market cap or net worth of 13.03 billion as of October 20, 2025. Its market cap has decreased by -54.76% in one year.
Market Cap
13.03B
Enterprise Value
15.38B
Revenue
116.55B
Ranking
n/a
PE Ratio
8.69
Stock Price
35.99
Market Cap Chart
Since December 13, 2001, Centene's market cap has increased from 10.73M to 13.03B, an increase of 121,333.43%. That is a compound annual growth rate of 34.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 17, 2025 | 12.93B | -47.06% |
| Dec 31, 2024 | 24.43B | -21.50% |
| Dec 29, 2023 | 31.12B | -19.25% |
| Dec 30, 2022 | 38.54B | 8.54% |
| Dec 31, 2021 | 35.51B | 39.29% |
| Dec 31, 2020 | 25.49B | 29.78% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.74B |
| GSK plc | 65.34B |
| Haleon | 31.33B |
| Smith & Nephew | 11.41B |
| ConvaTec Group | 4.82B |
| Hikma Pharmaceuticals | 3.93B |
| HUTCHMED (China) | 1.89B |
| Genus | 1.82B |